Cas 225528-29-0,Methyl 4-((N-3,5-dichlorophenylsulfonyl)aminomethyl)-3-(fluoro)-benzoate

225528-29-0

Post Buying Request

Basic information

Product Name: Methyl 4-((N-3,5-dichlorophenylsulfonyl)aminomethyl)-3-(fluoro)-benzoate
Synonyms: Methyl 4-((N-3,5-dichlorophenylsulfonyl)aminomethyl)-3-(fluoro)-benzoate
CAS NO:225528-29-0
Molecular Formula:
Molecular Weight: 392.235
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Methyl 4-((N-3,5-dichlorophenylsulfonyl)aminomethyl)-3-(fluoro)-benzoate(CAS DataBase Reference)
NIST Chemistry Reference: Methyl 4-((N-3,5-dichlorophenylsulfonyl)aminomethyl)-3-(fluoro)-benzoate(225528-29-0)
EPA Substance Registry System: Methyl 4-((N-3,5-dichlorophenylsulfonyl)aminomethyl)-3-(fluoro)-benzoate(225528-29-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 225528-29-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

225528-29-0 Suppliers

Recommended suppliers

225528-29-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 225528-29-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,5,5,2 and 8 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 225528-29:
(8*2)+(7*2)+(6*5)+(5*5)+(4*2)+(3*8)+(2*2)+(1*9)=130
130 % 10 = 0
So 225528-29-0 is a valid CAS Registry Number.

225528-29-0Upstream product

225528-29-0Downstream Products

225528-29-0Relevant academic research and scientific papers

Para-aminomethylaryl carboxamide derivatives

-

, (2008/06/13)

para-Aminomethylaryl carboxamides of Formula I are antagonists of VLA-4 and/or α4β7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 225528-29-0